Interstitial lung abnormalities are more prevalent in individuals with PRISm, and those with PRISm and ILAs have higher all-cause mortality.

In a phase 4 trial, dupilumab effectively reduces airway inflammation and mucus plugging, improving lung function and asthma control in patients with moderate to severe type 2 asthma.

Lung cancer rates vary by subtype and adenocarcinoma incidence worldwide, likely due to differences in air pollution, smoking, and generational patterns.

The abnormal accumulation of extravascular fluid, pulmonary edema settles in the lung interstitium and alveoli. There, it ...

A recent analysis shows that additional invasive staging modalities lead to relevant changes in target volume in some ...

The first volume of Angelou’s seven volumes of autobiography is a blisteringly good read. Tracing her life growing up in ...

Pulmonary rehabilitation significantly improves physical capacity, lung function, and quality of life in long COVID patients, with the greatest benefits seen in 4-8 week programs combining breathing ...

New GOLD guidelines recommend using pre-bronchodilator spirometry to rule out COPD and post-bronchodilator measurements to ...

Mar. 12, 2025 — A lung function test used to help diagnose asthma works better in the morning, becoming less reliable throughout the day, researchers have found. Using real world data from 1,600 ...

Asthma is caused by a combination of factors. People who develop asthma may have a genetic predisposition and react to ...